Literature DB >> 11483831

Brain white-matter lesions in celiac disease: a prospective study of 75 diet-treated patients.

M Kieslich1, G Errázuriz, H G Posselt, W Moeller-Hartmann, F Zanella, H Boehles.   

Abstract

OBJECTIVE: Celiac disease (CD), or gluten sensitivity, is considered to be a state of heightened immunologic responsiveness to ingested gluten proteins in genetically predisposed individuals. The gastrointestinal manifestation suggests a severe enteropathy of the small intestine with malabsorption, steatorrhea, and weight loss because of a deranged mucosal immune response. Neurologic complications occur, especially epilepsy, possibly associated with occipital calcifications or folate deficiency and cerebellar ataxia. There have been reports of brain white-matter lesions as an extraintestinal manifestation in Crohn disease and ulcerative colitis but not in CD.
METHODS: In this study, 75 diet-treated mainly pediatric patients with biopsy-proven CD underwent prospectively clinical neurologic examinations, laboratory investigations, electroencephalography, computed tomography, and magnetic resonance imaging. The age range was 2.8 to 24.2 years with a mean of 11.6 years. The mean period of gluten exposure was 2.4 years.
RESULTS: Ten patients had neurologic findings such as febrile seizures, single generalized seizures, mild ataxia, and muscular hypotonia with retarded motor development. No folate deficiency was found. The hippocampal regions showed no abnormalities. Computed tomography did not reveal any cerebral calcifications, but magnetic resonance imaging detected unilateral and bilateral T2-hyperintensive white-matter lesions in 15 patients (20%). There was no correlation between these lesions and dietary compliance or neurologic or electroencephalographic abnormalities. The mean gluten exposure time of these patients was slightly increased (not significant).
CONCLUSIONS: Focal white-matter lesions in the brain may represent an extraintestinal manifestation of CD. They may be ischemic in origin as a result of a vasculitis or caused by inflammatory demyelination. They seem to be more typical of pediatric CD than cerebral calcifications. Their prognostic value is unclear and needs to be elucidated in additional studies. CD should be suggested as a differential diagnosis in children with unclear white-matter lesions even without intestinal symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11483831     DOI: 10.1542/peds.108.2.e21

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

1.  Prevalence and demographic characteristics of celiac disease among blood donors in Ribeirão Preto, State of São Paulo, Brazil.

Authors:  Suzeidi Bernardo Castanheira Melo; Maria Inez Machado Fernandes; Luiz Cesar Peres; Luiz Ernesto Almeida Troncon; Livia Carvalho Galvão
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

2.  Celiac sprue: a unique autoimmune disorder.

Authors:  Shadi Rashtak; Eric V Marietta; Joseph A Murray
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

3.  Silent neurological involvement in biopsy-defined coeliac patients.

Authors:  Basar Bilgic; Demet Aygun; Ali Bilgin Arslan; Ali Bayram; Filiz Akyuz; Serra Sencer; Hasmet A Hanagasi
Journal:  Neurol Sci       Date:  2013-04-25       Impact factor: 3.307

Review 4.  Neuroimaging of rapidly progressive dementias, part 2: prion, inflammatory, neoplastic, and other etiologies.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-14       Impact factor: 3.825

Review 5.  Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.

Authors:  Jessica R Jackson; William W Eaton; Nicola G Cascella; Alessio Fasano; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2012-03

6.  A pediatric case of gluten sensitivity with severe neurological presentation.

Authors:  R Jorge; C Aguiar; C Espinheira; E Trindade; A M Maia; R Sousa
Journal:  Eur J Pediatr       Date:  2014-05-13       Impact factor: 3.183

7.  In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.

Authors:  I R Korponay-Szabó; T Halttunen; Z Szalai; K Laurila; R Király; J B Kovács; L Fésüs; M Mäki
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 8.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

9.  TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities.

Authors:  Wojciech Wiszniewski; Jill V Hunter; Neil A Hanchard; Jason R Willer; Chad Shaw; Qi Tian; Anna Illner; Xueqing Wang; Sau W Cheung; Ankita Patel; Ian M Campbell; Violet Gelowani; Patricia Hixson; Audrey R Ester; Mahshid S Azamian; Lorraine Potocki; Gladys Zapata; Patricia P Hernandez; Melissa B Ramocki; Regie L P Santos-Cortez; Gao Wang; Michele K York; Monica J Justice; Zili D Chu; Patricia I Bader; Lisa Omo-Griffith; Nirupama S Madduri; Gunter Scharer; Heather P Crawford; Pattamawadee Yanatatsaneejit; Anna Eifert; Jeffery Kerr; Carlos A Bacino; Adiaha I A Franklin; Robin P Goin-Kochel; Gayle Simpson; Ladonna Immken; Muhammad E Haque; Marija Stosic; Misti D Williams; Thomas M Morgan; Sumit Pruthi; Reed Omary; Simeon A Boyadjiev; Kay K Win; Aye Thida; Matthew Hurles; Martin Lloyd Hibberd; Chiea Chuen Khor; Nguyen Van Vinh Chau; Thomas E Gallagher; Apiwat Mutirangura; Pawel Stankiewicz; Arthur L Beaudet; Mirjana Maletic-Savatic; Jill A Rosenfeld; Lisa G Shaffer; Erica E Davis; John W Belmont; Sarah Dunstan; Cameron P Simmons; Penelope E Bonnen; Suzanne M Leal; Nicholas Katsanis; James R Lupski; Seema R Lalani
Journal:  Am J Hum Genet       Date:  2013-06-27       Impact factor: 11.025

10.  Brain involvement in patients with inflammatory bowel disease: a voxel-based morphometry and diffusion tensor imaging study.

Authors:  Anastasia K Zikou; Maria Kosmidou; Loukas G Astrakas; Loukia C Tzarouchi; Epameinondas Tsianos; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2014-07-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.